retatrutide clinical trial (GLP-3) Results: What Trials Actually Show Retatrutide, an investigational triple hormone

The biomarker trap: engagement is not benefit The most important lesson of the trial is also the most uncomfortable

Allergy to sitagliptin or any inactive ingredient Severe kidney disease or dialysis History of heart failure or pancreatitis Alcohol use, gallstones, high triglycerides Pregnancy or plans to become pregnant Breastfeeding or plans to breastfeed What drug interactions are there with Januvia

Avoid lying down immediately after eating, and stay away from greasy, fried, or very spicy foods as they can worsen symptoms

Protein + fiber first

Edwin Lephart is an editorial board member of Dermatology and Therapy